Tilidine: Effect, Risks and Safe Use of the Painkiller

Tilidine is a WHO-step-II opioid painkiller and in Germany almost always available in a fixed combination with naloxone, known as Valoron N. About 4 million pain patients in Germany receive opioids (a German figure), many of them tilidine as an entry point before stronger substances. Unlike the prolonged-release tablets, which are not controlled drugs, the fast-acting drops have been subject to Germany's controlled-drugs law since 2013 — misuse had increased above all among adolescents. (Note: tilidine is a continental-European opioid and is not marketed in the UK or US.)

See more detail

1. At a Glance: Technical Data Sheet

Tilidine is an opioid painkiller of WHO step II, in Germany almost always in a fixed combination with naloxone. Below are the key facts for quick orientation; the individual points are explained in detail in the following chapters.

PropertyDetails
Active substanceTilidine (a prodrug, active as nortilidine) - usually with naloxone
Trade namesValoron N, tilidine-naloxone generics - drops and prolonged-release tablets
ATC codeN02AX51 - opioids in combination
WHO stepII - a moderately strong opioid
Mechanism of actionActivation of μ-opioid receptors (nortilidine); the naloxone component blocks the high in case of misuse (i.v.)
Main indicationsModerate to severe pain when non-opioid painkillers are not enough
Usual doseProlonged-release tablets twice daily; drops as needed - individually by a doctor
Onset of actionDrops 10-30 min; prolonged-release tablets delayed over hours
Controlled-drug statusDrops subject to controlled-drug regulations (BtM) since 2013; prolonged-release tablets not subject to BtM
Most important risksRespiratory depression (especially with alcohol/benzodiazepines), dependence, constipation
AntidoteNaloxone (also in the preparation, an emergency-doctor antidote)
Table scrollable to the right

2. What is tilidine?

Tilidine is an opioid painkiller used for moderate to severe pain when weaker painkillers are not enough. It belongs to the weak to moderately strong opioids (WHO step II) and is offered in Germany almost always in a fixed combination with the active substance naloxone - known under the trade name Valoron N. This combination has an important safety reason, which we explain in detail.

Tilidine is an effective painkiller that is well controllable with correct use. In recent years, however, it has also gained sad notoriety through misuse - especially among young people and in certain scenes. This has led to stricter regulations and makes factual education about its effect, risks and safe use particularly important.

Like all opioids, tilidine can be addictive and dangerous in overdose - especially in combination with other depressant substances. At the same time, it is a valuable medicine for many pain patients. This article explains responsible use, without trivialising and without dramatising.

3. How does tilidine work pharmacologically?

Tilidine itself is at first barely active - it is a so-called prodrug. Only in the liver is it converted into the actually active substance nortilidine. Nortilidine binds to the opioid receptors (especially μ-receptors) in the central nervous system and there dampens the perception and transmission of pain - similar to the body's own endorphins, only stronger.

This activation of the opioid receptors brings about the pain-relieving effect, but is also responsible for the typical opioid side effects: fatigue, constipation, nausea, and at high doses the dangerous respiratory depression. The potential for dependence also rests on the effect at these receptors - via the body's own reward system.

Pharmacokinetics in brief

Tilidine is well absorbed after oral intake and converted in the liver to nortilidine. The effect of the drops sets in rapidly (within 10-30 minutes), that of the prolonged-release tablets delayed and evenly over hours. Metabolism via the liver also means: with severe liver dysfunction, the conversion to the active nortilidine can be impaired, which changes the effect.

4. Why tilidine is combined with naloxone

A clever and important safety principle that distinguishes tilidine from other opioids. The combination partner naloxone is an opioid antagonist - it blocks the opioid receptors and cancels the opioid effect. Why combine a painkiller with its own antagonist? The answer lies in the different behaviour depending on the route of intake.

With correct intake (swallowed)

If tilidine/naloxone is swallowed as intended, the naloxone is almost completely broken down on the first liver passage (a strong first-pass effect) - it has practically no effect. The tilidine, on the other hand, is converted to the active nortilidine and can fully develop its pain-relieving effect. With intended use, the naloxone therefore does not interfere.

With misuse (injected or overdosed)

If, on the other hand, the medicine is injected for misuse (intravenously) to achieve a high, the naloxone bypasses the liver - and immediately blocks the opioid receptors. The hoped-for high fails to materialise, and in opioid-dependent people withdrawal can even be triggered. Even with massive oral overdose, naloxone can partly counteract.

This protection against misuse is the reason for the combination - it is intended to make intravenous misuse unattractive. Misuse cannot be completely prevented by this, however, which explains the additional regulatory measures (see the chapter on drops vs. tablets).

5. What is tilidine used for?

Tilidine is used for moderate to severe pain that cannot be adequately treated with non-opioid painkillers (such as ibuprofen, paracetamol, metamizole):

  • Acute severe pain - e.g. after injuries or operations
  • Chronic pain - e.g. with degenerative joint diseases, back pain, when other agents are not enough
  • Cancer pain - as part of a stepwise pain concept (the WHO step ladder)
  • Neuropathic pain - in certain cases as a supplement

Tilidine sits on step II of the WHO step ladder of pain therapy - between the non-opioid painkillers (step I) and the strong opioids such as morphine (step III). It is often combined with non-opioid painkillers to attack at various points of pain development. The indication and dosing are determined by the doctor within a well-thought-out pain concept.

6. Drops vs. prolonged-release tablets — an important difference

A central and safety-relevant difference with tilidine - the two dosage forms behave completely differently and are subject to different rules:

AspectTilidine dropsTilidine prolonged-release tablets
Onset of actionFast (10-30 min)Slow, evenly over hours
SurgeFast surge - a noticeable effectNo fast surge
Misuse potentialHigherLower
Legal statusSubject to controlled-drug regulations (BtM) since 2013Normal prescription (not BtM)
IndicationAcute pain peaks, as-needed medicationLong-term therapy of chronic pain
AdvantagesFast help with pain peaksEven pain protection, lower misuse risk
Table scrollable to the right

This distinction explains the different regulation: the fast-surging drops were made subject to controlled-drug regulations (BtM) in 2013, after their misuse - especially among young people - had increased. For the long-term therapy of chronic pain, the prolonged-release tablets are standard, because they act more evenly and have less misuse potential.

7. Dosage and intake

The dosing is always determined individually by the doctor - depending on the pain intensity, prior experience with opioids and general condition:

  • Prolonged-release tablets: usually twice daily (every 12 hours) for even pain protection
  • Drops: as needed on medical instruction, with a defined maximum amount
  • Gradual starting at the beginning of long-term therapy - start low, adjust slowly
  • Hepatic impairment: caution - the conversion to the active nortilidine can be impaired
  • The maximum dose as specified by a doctor is to be strictly observed

The most important intake notes

  • Take exactly as instructed by a doctor - never increase the dose on your own
  • Swallow prolonged-release tablets whole - do not chew or split them (that would release the entire dose at once - dangerous)
  • Think about constipation prophylaxis alongside - opioids almost always constipate (see side effects)
  • Do not combine with alcohol or other depressant substances
  • Caution when driving - especially at the start and with dose changes
  • Never stop abruptly after prolonged use - taper

8. Dependence and misuse

A central and serious topic with tilidine. Like all opioids, tilidine can cause physical and psychological dependence. The risk depends strongly on the dosage form, dose, duration and individual factors.

Dependence with intended pain therapy

With correct use in pain therapy - especially with prolonged-release tablets and under medical supervision - the risk of dependence is manageable but present. With prolonged use, a physical habituation develops, so that withdrawal symptoms can occur on stopping (see the stopping chapter). This is not the same as an addiction, but requires a controlled tapering.

Misuse

Tilidine - especially the drops - has in recent years gained sad notoriety through misuse, partly promoted by its portrayal in certain music and social media. The misuse aims at the depressant, euphoric or disinhibiting effect. The naloxone combination and the controlled-drug status of the drops are intended to counteract this.

Tilidine misuse is dangerous A risk of dependence, respiratory depression (especially with alcohol or other depressant substances), accidents and severe health damage. Tilidine may only be taken on medical prescription and exactly as instructed - never to get high, never pass it on to others.

Warning signs of problematic use

  • Dose escalation beyond the medical prescription
  • Intake without pain, to influence the mood
  • Craving, a mental preoccupation with the medicine
  • Obtaining from several sources, prescription forgery
  • A loss of control over the intake

With such signs, medical help is important - an opioid dependence is treatable, and acting early is decisive.

9. Common side effects

Tilidine has the typical opioid side effects. Common, especially at the start:

  • Nausea and vomiting - especially in the initial phase, often improves over the course
  • Constipation - the most stubborn opioid side effect, hardly improves on its own; prevention is important
  • Fatigue, drowsiness, grogginess
  • Dizziness - especially on standing up
  • Headaches
  • Sweating
  • Dry mouth
  • Mood changes

Particularly important - the constipation: unlike most other opioid side effects, the opioid-related constipation does not disappear through habituation. With prolonged use, an accompanying treatment (a high-fibre diet, drinking enough, laxatives prescribed by a doctor if necessary) is therefore important.

10. Respiratory depression and overdose

The most dangerous risk of all opioids - tilidine too. In overdose, opioids can dampen the breathing (respiratory depression) up to respiratory arrest. This is the most common reason for fatal opioid poisonings.

  • The risk rises sharply in overdose and in combination with other depressant substances (alcohol, sedatives, sleeping pills, other opioids)
  • Particularly at risk: opioid-naive people, older people, patients with respiratory diseases, with liver dysfunction
  • Warning signs: very slow or shallow breathing, extreme drowsiness up to unrousability, pinpoint pupils, bluish lips/skin, confusion
Call the emergency services immediately (112; or 999/112 in the UK) on suspicion of an opioid overdose With very slow/shallow breathing, unrousability, blue lips or pinpoint pupils. The antidote naloxone can reverse the respiratory depression - the ambulance service and emergency doctors carry it. Until they arrive: speak to the person, keep them awake, place them in the recovery position if unconscious, monitor the breathing.

With intended use in pain therapy, the respiratory-depression risk is low - it becomes critical with overdose and dangerous combinations. That is precisely why the maximum dose and the alcohol ban are so important.

11. Interactions with other medicines

Tilidine has clinically very relevant interactions - especially with other depressant substances:

Substance/categoryEffectRecommendation
AlcoholEnhanced depression and respiratory depressionStrictly avoid - life-threatening
Benzodiazepines (diazepam, lorazepam, Tavor and others), Z-drugs (zolpidem)Strongly increased respiratory-depression riskA dangerous combination - only under strict indication
Other opioidsAdditive effect, respiratory depressionNever without medical instruction
Sedating antidepressants (mirtazapine, tricyclics)Enhanced depressionCaution, low doses
AntipsychoticsEnhanced sedationCaution
Gabapentin, pregabalinIncreased respiratory-depression risk (BfArM warning)Only under medical supervision
Buprenorphine, naltrexone (opioid antagonists)Can cancel the tilidine effect or trigger withdrawalDo not combine
Liver-enzyme-modifying medicinesCan change the conversion to nortilidineConsult a doctor
Table scrollable to the right

The combination with benzodiazepines is particularly critical and a common factor in opioid deaths. Before any new medication, consult a doctor/pharmacist. More under Interactions of medicines and Taking medicines correctly.

12. Tilidine and alcohol

Tilidine and alcohol must not be combined! Both depress the central nervous system - together they enhance each other and can lead to dangerous respiratory depression, unconsciousness and in the worst case death. This combination is one of the most common reasons for severe incidents with opioids.

The danger is real and is often underestimated: while tilidine at a therapeutic dose alone is usually well tolerated, even a moderate amount of alcohol can dangerously enhance the depressant effect. This applies to all dosage forms. Throughout the entire tilidine therapy, alcohol should be consistently avoided - even small amounts.

13. Stopping tilidine correctly

After prolonged use, tilidine must not be stopped abruptly - the body has become accustomed to the opioid, and a sudden stop triggers a withdrawal syndrome:

Possible withdrawal symptoms: restlessness, anxiety, sleep disturbances, sweating, goosebumps, muscle and limb pain, abdominal cramps, diarrhoea, nausea, a racing heart, watering eyes and a runny nose, a strong craving. These are unpleasant but largely avoidable with controlled tapering.

  • Never stop abruptly after prolonged use
  • Stepwise tapering over days to weeks, depending on the duration of therapy and dose - with medical support
  • With stronger withdrawal symptoms slow the pace
  • If the cause of the pain disappears (e.g. after healing), end the therapy actively and in a planned way instead of uncontrolled
  • Medical support is important - it makes stopping safe and bearable

The occurrence of withdrawal symptoms on abrupt stopping is an expression of the physical habituation and not a sign of moral failure. With planned tapering, stopping is well achievable.

14. Tilidine in older people

  • An increased sensitivity to the depressant effects - a higher risk of falls, confusion and respiratory depression
  • Constipation is particularly burdensome in old age - consistent prevention
  • A fall risk due to dizziness and grogginess - especially at the start
  • Polypharmacy - an increased interaction risk, especially with other sedating agents
  • Liver and kidney function often limited in old age - caution, cautious dosing
  • Start low, increase slowly ("start low, go slow")
  • Cognitive impairment can make correct intake more difficult - support is sensible

15. When to see a doctor? (Warning signs)

  • Very slow or shallow breathing, extreme drowsiness - suspected respiratory depression (an emergency)
  • Signs of problematic use (dose escalation, craving, loss of control)
  • Persistent, distressing constipation
  • Pronounced fatigue, confusion
  • An absence of pain relief despite therapy
  • A wish to stop the medicine - for a supported tapering
  • Severe nausea/vomiting that does not subside
  • Signs of an allergic reaction
  • Accidental overdose or intake by others (especially children)
Call the emergency services immediately (112; or 999/112 in the UK) With very slow/shallow breathing, unrousability, blue lips (suspected opioid overdose), a seizure, a severe allergic reaction. With accidental intake by children, contact the poison control centre/an emergency doctor immediately - opioids are dangerous for children even in small amounts.

16. What you can do yourself: 10 Golden Rules

  1. Take exactly as instructed by a doctorStrictly observe the dose and frequency, never increase on your own.
  2. Never combine with alcoholLife-threatening respiratory depression possible - avoid even small amounts.
  3. No additional depressant agents without consultationEspecially no sleeping pills or sedatives.
  4. Prevent constipationA high-fibre diet, drinking enough, exercise, laxatives if necessary.
  5. Caution when driving and operating machineryEspecially at the start and with dose changes.
  6. Store safelyProtect from children and from access by others - a misuse and poisoning risk.
  7. Never pass it on to othersNot even with similar complaints - opioids are prescribed individually.
  8. Never stop abruptlyAfter prolonged use, taper with medical support.
  9. Watch for warning signs of problematic useTake dose escalation, craving, loss of control seriously.
  10. Keep a pain diaryHelps to optimise the therapy and find the lowest effective dose.

17. How brite supports you with tilidine

Transparency notice brite is a health app. The following functions relate to features of the app and do not replace medical pain therapy.
  • Intake reminder: take tilidine (especially the prolonged-release tablets) on time and regularly - brite reminds you reliably for even pain protection.
  • Interaction check: check the alcohol note, benzodiazepines, other opioids and sedating medicines free of charge - recognise critical combinations.
  • Document the discontinuation plan: accompany the stepwise tapering in a structured way.
  • Health history: document the pain intensity, effect and side effects - valuable for medical pain therapy and the search for the lowest effective dose.
  • Digital medication plan: all medicines clearly laid out for your GP, pain specialist, pharmacy and emergency doctors.
Register for free now

Real-world data: what brite users report

Note Anonymised observations from brite app user data, do not replace clinical studies.
ObservationFrequencyTypical comment
Constipation as the main problem after weeksVery common"After 3 weeks of tilidine for back pain, the constipation was worse than the pain - my GP then prescribed a laxative alongside straight away."
Self-directed dose escalation with toleranceCommon"I increased the dose myself because it no longer worked - instead of going to the doctor, which would have been much wiser."
Respiratory depression with pregabalinRare but dramatic"My father took tilidine and Lyrica - one night he was barely breathing, the ambulance service gave naloxone."
Accidentally beer in the eveningCommon"I had forgotten I had taken tilidine in the morning - the beer in the evening knocked me out completely, I could barely stand."
Withdrawal after self-stoppingCommon"After 3 months I thought I was cured - the abrupt stopping was hell, now with a pain specialist for structured tapering."
Drop misuse in the family environmentCommon"My drops were suddenly empty - my son (16) had shared them for 'fun' with friends, a bad wake-up call for everyone."
Table scrollable to the right

Tilidine experiences: what patients really ask

Tilidine experiences with chronic pain - how long may one take it? That is an individual decision of the pain specialist. With chronic non-cancer pain, the German LONTS guideline recommends a cautious indication and a regular review of the benefit. Typical treatment durations: acute postoperative pain days to weeks, acute back-pain flares a few weeks, chronic degenerative pain months to years (with regular pause attempts), cancer pain often lifelong. Risks of long-term therapy: tolerance development (ever higher doses for the same effect), dependence, opioid-induced hyperalgesia (a paradoxical intensification of pain by the opioids themselves), hormonal disturbances, constipation. Practically: consider an attempt to omit it every 3-6 months, to test whether the opioid is still needed.

Tilidine experiences with addiction - how do I notice that I am dependent? An honest and important question. Early warning signs: I take the tablets prophylactically before the pain, I often think about the next dose, I am afraid of "no longer having it", I go to several doctors for prescriptions. Middle stages: dose escalation beyond the medical prescription, concealing the intake from family/doctors, social activities are planned around the intake. Late stages: loss of control, use despite negative consequences, physical withdrawal symptoms with longer pauses. Important: physical habituation (withdrawal symptoms on stopping) is not the same as addiction - it also occurs with purely medical use. True addiction additionally has the psychological component (craving, loss of control). On suspicion: an honest conversation with the doctor, addiction counselling, in severe cases inpatient withdrawal - all options exist without stigma.

Tilidine vs. tramadol - which is better? Both are WHO step II opioids with similar pain relief, but with important differences. Tilidine advantages: the naloxone misuse protection, a prolonged-release form for long-term therapy without a controlled-drug prescription, well controllable. Tilidine disadvantages: drops subject to controlled-drug regulations, a higher misuse potential of the drops, liver-dependent metabolism (caution with liver damage). Tramadol advantages: not subject to controlled-drug regulations, an additional serotonergic/noradrenergic effect (good with neuropathic pain), often cheaper. Tramadol disadvantages: a serotonin syndrome risk with SSRI combination, a higher seizure risk, a higher side-effect profile (nausea). Rule of thumb: with a neuropathic-pain component tramadol, with purely nociceptive pain tilidine, with SSRI therapy rather tilidine (no serotonin syndrome risk). Both with caution with a history of addiction.

Tilidine in the rap scene - what is behind it? A sad cultural reality. Tilidine drops became, in the 2010s, a symbol of certain German rap subcultures, with massive trivialisation in songs and social media. The effect in misuse doses: euphoria, disinhibition, insensitivity to pain, an overestimation of oneself - this explains the "coolness" staging. The reality: rapid tolerance development, dependence within weeks, respiratory arrest with combinations, social and health destruction. Several artists have died from tilidine or mixed use. The authorities' reaction: in 2013 the controlled-drug status of the drops, school prevention programmes, more education. Parents should know: if tilidine is prescribed in the household (e.g. after an operation), store it safely - its availability in one's own medicine cabinet is a gateway risk.

Getting rid of tilidine constipation - what really helps? The opioid-induced constipation is the most stubborn opioid side effect and does not disappear through habituation. Basic measures (often not enough): 2-3 litres of water daily, a high-fibre diet (wholegrain, fruit, vegetables), regular exercise, prunes, linseed. Usually needed with prolonged opioid therapy: osmotic laxatives such as macrogol (well tolerated, the agent of choice), stimulants such as bisacodyl (OK in the short term), lactulose. On failure: special PAMORA agents such as naloxegol or methylnaltrexone - they specifically block the opioid receptors in the gut without cancelling the pain relief. Important: treat constipation early and prophylactically - do not wait until it is there. At the start of every opioid therapy, start straight away with macrogol.

FAQ: Common questions about tilidine

Naloxone is an opioid antagonist and serves as protection against misuse. With correct swallowing, naloxone is almost completely broken down in the liver and does not interfere - the tilidine works normally. If, on the other hand, the medicine is injected for misuse, the naloxone bypasses the liver, blocks the opioid receptors and prevents the high (in dependent people it can trigger withdrawal). This clever combination is intended to make intravenous misuse unattractive.
Yes - like all opioids, tilidine can be addictive. With correct pain therapy under medical supervision (especially with prolonged-release tablets), the risk is manageable but present; with prolonged use, a physical habituation develops with withdrawal symptoms on stopping. The risk is considerably higher with misuse, especially of the fast-acting drops. Take tilidine only on medical instruction, never to get high.
The drops act quickly (10-30 minutes) and briefly - hence a higher misuse and dependence potential; they have been subject to controlled-drug regulations (BtM) since 2013. The prolonged-release tablets release the active substance slowly and evenly over hours - a lower misuse potential, not subject to BtM. For the long-term therapy of chronic pain, the prolonged-release tablets are standard, the drops rather for acute pain peaks.
No - on no account. Tilidine and alcohol both depress the central nervous system and enhance each other. The combination can lead to dangerous respiratory depression, unconsciousness and in the worst case death - it is one of the most common reasons for severe opioid incidents. Throughout the entire therapy, consistently avoid alcohol, even small amounts.
Very dangerous - as with all opioids, there is a threat of respiratory depression up to respiratory arrest, the most common reason for fatal opioid poisonings. The risk rises sharply in combination with alcohol or sedatives. Warning signs: very slow/shallow breathing, unrousability, pinpoint pupils, blue lips. On suspicion, call the emergency services immediately (112; or 999/112 in the UK) - the antidote naloxone can reverse the respiratory depression.
After prolonged use, not abruptly - the body has become accustomed, and a sudden stop triggers withdrawal symptoms (restlessness, sweating, muscle pain, nausea, diarrhoea, craving). Tilidine should be tapered stepwise and with medical support. With planned tapering, stopping is well achievable. If the cause of the pain disappears, end the therapy actively and in a controlled way.
Tilidine works for moderate to severe pain when non-opioid painkillers are not enough - it sits on step II of the WHO scheme. It is not equally well suited to every pain, however; with certain forms of pain (e.g. neuropathic pain), other agents are often more effective or are added. The selection belongs in a well-thought-out medical pain concept, often in combination with non-opioid agents.
Opioids such as tilidine slow the bowel movement via the opioid receptors in the gut - constipation is the typical consequence. Unlike most opioid side effects, it does not disappear through habituation, but persists. That is why, with prolonged use, an accompanying prevention is important: a high-fibre diet, drinking enough, exercise and often a laxative prescribed by a doctor.
Tilidine can make you tired and groggy and impair your reaction ability - especially at the start and with dose changes. In this phase, a car should not be driven. With a stable setting on a constant dose, driving may be possible, but that is individual and to be clarified with the doctor. In combination with alcohol or other depressant agents, driving is fundamentally taboo.
That depends on the dosage form: the fast-acting tilidine drops have been subject to controlled-drug regulations (BtM prescription) since 2013 - because of the misuse. The prolonged-release tablets in a fixed combination with naloxone, on the other hand, are not subject to controlled-drug regulations and are prescribed on a normal prescription, because their misuse potential is lower due to the slow release. Both are prescription-only.

Sources

  1. IQWiG (Germany) — gesundheitsinformation.de: opioids, pain therapy. gesundheitsinformation.de
  2. S3 guideline on the long-term use of opioids in chronic non-cancer pain (LONTS, AWMF 145-003) (Germany). awmf.org
  3. Federal Institute for Drugs and Medical Devices (BfArM, Germany) — controlled-drug law, tilidine. bfarm.de
  4. Drug Commission of the German Medical Association (AkdÄ, Germany) — opioids. akdae.de
  5. German Pain Society (Germany). schmerzgesellschaft.de
Medical disclaimer: This article serves general information and does not replace medical advice, diagnosis or therapy. Tilidine is an opioid painkiller with a potential for dependence and may only be taken on medical prescription and exactly as instructed. Never combine with alcohol or sedatives - a danger of life-threatening respiratory depression. After prolonged use, do not stop abruptly. With very slow/shallow breathing, unrousability or blue lips, call the emergency services immediately (112; or 999/112 in the UK). Last updated: May 2026.